Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DB25FZNA0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,551
Award facts
- Contract value 100% obligated
- $5,550.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $5,550.84 to DMS Pharmaceutical Group Inc. for the supply of Botox 100 unit vials. The award, issued on September 29, 2025, with an ultimate completion date of October 21, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at approximately $500 million and extending through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, with a robust portfolio of delivery orders for diverse medical products including prescription medications, biologics, vaccines, and specialty pharmaceuticals. The company's track record demonstrates consistent success in competing for federal pharmaceutical contracts without specific set-aside protections, leveraging its woman-owned small business status and established registration with SAM.gov since 2001. This Botox delivery order exemplifies the company's ongoing role in supplying specialized pharmaceutical products to military health facilities across the defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB25FZNA0?
SPE2DB25FZNA0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FZNA0 worth?
The government has obligated $5,551 on SPE2DB25FZNA0.
Is contract SPE2DB25FZNA0 an order under another contract?
Yes. SPE2DB25FZNA0 is a delivery order under SPE2DB24D9210, an indefinite delivery contract.
Was contract SPE2DB25FZNA0 competed?
The extent of competition for SPE2DB25FZNA0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award